Start with these research questions
How to read the evidence
Distinguish research methods, product-specific results, and regulatory requirements. Method suitability needs molecule-specific evaluation.
Sources, selection, and corrections →Explore analytical evidence for structure, heterogeneity, potency, and comparability.
Distinguish research methods, product-specific results, and regulatory requirements. Method suitability needs molecule-specific evaluation.
Sources, selection, and corrections →Verified against public sources, selective and unranked. Drug developers and service providers are labeled separately. Unverified financing, founding dates, and current pipeline stages are not inferred.
Crystal Bio Solutions offers Biologics mass spectrometry, CMC analytics, PK, immunogenicity and biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →ProtaGene offers Protein structure, impurities, potency and analytical comparability. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →BioAgilytix offers Large-molecule PK, ADA, neutralizing antibodies, biomarkers and CMC analytics. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Frontage Laboratories offers Analytical development, GMP release, bioanalysis and biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Charles River Laboratories offers Protein characterization, biosafety, PK/TK, immunogenicity and biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →SGS offers Protein characterization, potency, GMP release, stability and bioanalysis. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Eurofins BioPharma Services offers Biologics characterization, GMP testing, bioanalysis and clinical biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Intertek offers Protein structure, higher-order structure, GMP testing, PK and immunogenicity. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Solvias offers Biologics characterization, impurities, potency and CMC quality testing. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Alcami offers Biologics analytical development, validation, stability and GMP release. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Pace Life Sciences offers Biologics analytical testing, potency and GMP quality control. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →BioPharmaSpec offers Protein sequencing, higher-order structure, glycans and comparability. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Alphalyse offers Mass spectrometry, protein identification and host-cell protein analysis. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Coriolis Pharma offers Biophysical characterization, formulation and stability of biologics. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →LEUKOCARE offers Biologics formulation, stability and particle characterization. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Reading Scientific Services (RSSL) offers Biologics structure, glycans, impurities, GMP release and stability. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Biofidus offers Protein structure, mass spectrometry, glycans and biophysical characterization. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →NUVISAN offers Large-molecule QC testing, bioanalysis and clinical biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Selvita offers Biologics characterization, analytical development and quality control. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Emery Pharma offers Biologics mass spectrometry, NMR, structural characterization and impurities. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Avance Biosciences offers Biologics and gene-therapy analytical testing, potency and molecular assays. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Texcell offers Biosafety, cell-bank characterization and bioassays. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Clean Cells offers Biologics potency, biosafety and cell-bank characterization. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Merck BioReliance offers Biologics biosafety, cell-bank characterization and GMP testing. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →KABS Pharmaceutical Services offers Analytical development, validation and quality control for biopharmaceuticals. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Custom Biologics offers Biologics potency, functional assays, PK and immunogenicity. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Rapid Novor offers Antibody sequencing, mass spectrometry and characterization. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →BIOVECTRA offers Biologics analytical development, characterization and GMP testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Biodextris offers Vaccine and biologics analytical development, validation and quality testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →WuXi Biologics offers Biologics structure, higher-order structure, potency, release and stability. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Pharmaron offers Biologics characterization, PK/TK, immunogenicity and biomarkers. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →军科正源 (UP Pharma) offers Protein characterization, PK, ADA, neutralizing antibodies and biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →百趣生物 (Biotree) offers Protein characterization, developability and multiomics biomarkers. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →耀海生物 (Yaohai Bio-Pharma) offers Recombinant proteins, nanobodies and nucleic-acid characterization and QC. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →东曜药业 (BioDlink) offers Antibody and ADC characterization, higher-order structure and comparability. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →迈百瑞 (MabPlex) offers Antibody and ADC structure, potency, impurities and CMC analytics. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →鼎康生物 (Chime Biologics) offers Biologics analytical development, characterization, release and stability. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →ProBio offers Antibody and gene-therapy characterization, bioassays and quality control. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Samsung Biologics offers Biologics identity, purity, potency, release and stability testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →LOTTE Biologics offers Biologics method transfer, potency, release and stability testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →BINEX offers Biologics analytical development, validation and protein characterization. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Prestige Biologics offers Biologics analytical testing and analytical development within CDMO services. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Lonza offers Biologics analytical development, characterization and GMP testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →AGC Biologics offers Protein and cell/gene-therapy analytical development and quality testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →KBI Biopharma offers Biologics structure, biophysical characterization, potency and analytics. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Abzena offers Antibody and bioconjugate characterization and analytical development. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Curia offers Biologics analytical testing, bioassays and stability. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →FUJIFILM Biotechnologies offers Biologics biochemical and biophysical characterization, potency and GMP testing. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Northway Biotech offers Biologics analytical development, characterization and quality control. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Aragen Life Sciences offers Protein characterization, analytical development and clinical bioanalysis. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →Syngene International offers Biologics characterization, regulated bioanalysis and clinical biomarkers. This is the analytical service business of an integrated CRO/CDMO.
Sources checked: 2026-11-05
Profile & sources →VelaLabs offers Biologics characterization, GMP QC, potency and clinical bioanalysis. Services should be matched to the intended study and assay requirements.
Sources checked: 2026-11-05
Profile & sources →Original online dates are retained. Guides use accessible articles or abstracts and do not replace reading the paper.
This industry perspective examines native mass spectrometry as a complement to established biopharmaceutical characterization methods. It discusses intact assemblies, binding, stoichiometry, and heterogeneity, while identifying throughput, sensitivity, automation, and access limitations. The authors emphasize integration with analytical workflows rather than universal replacement of existing methods.
Elizabeth Hecht; Esther Martin; Idlir Liko; Andrew Mahan; Aniruddha Sahasrabuddhe; Nastaran N Tajoddin; Iain D G Campuzano
DOI: 10.1080/19420862.2026.2699078
Manually selected historical and recent original announcements, not presented as today’s news. Source dates, including historical dates, are retained.
BioAgilytix reviewed its earlier analytical investment in Morrisville and Hamburg, describing infrastructure for GMP QC, characterization, bioassays, release, and stability programs. This is a May 2026 company update about previously expanded capabilities, not a newly announced November facility opening or independent quality certification.
Original announcement ↗